Gill, Harinder
Leung, Garret M. K.
Ooi, Melissa G. M.
Teo, Winnie Z. Y.
Wong, Chieh-Lee
Choi, Chul Won
Wong, Gee-Chuan
Lao, Zhentang
Rojnuckarin, Ponlapat
Castillo, Ma. Rosario Irene D.
Xiao, Zhijian
Hou, Hsin-An
Kuo, Ming-Chung
Shih, Lee-Yung
Gan, Gin-Gin
Lin, Chien-Chin
Chng, Wee-Joo
Kwong, Yok-Lam
Article History
Received: 18 March 2023
Accepted: 4 September 2023
First Online: 25 September 2023
Declarations
:
: Harinder Gill has the following disclosures: research funding/grants from Celgene, Novartis Oncology and PharmaEssentia Corporation; investigator-initiated study collaborations with Imago Biosciences Inc., PharmaEssentia Corporation and Novartis; Consultancies for Abbvie, Astellas, BMS, GSK, Novartis Oncology and PharmaEssentia Corporation; Conference support from Novartis and PharmaEssentia Corporation. All other authors declare that they have no competing interest.